Pyrazolothiazepines and isoxazolothiazepines
    2.
    发明授权
    Pyrazolothiazepines and isoxazolothiazepines 失效
    吡咯并嘧啶和异佛尔泽菌素

    公开(公告)号:US3669983A

    公开(公告)日:1972-06-13

    申请号:US3669983D

    申请日:1970-08-20

    Applicant: ABBOTT LAB

    CPC classification number: C07D231/38

    Abstract: 7,8-Dihydro-4-oxopyrazolo(3,4-d) (1,3)thiazepines which may be substituted in the 1-, 3-, 5-, 7- and/or 8- position and the corresponding isoxazolo(5,4-d) (1,3)thiazepines which may be substituted in the 3-, 5-, 7- and/or 8- position are prepared by converting a 5-aminopyrazole which may be substituted in the 1and/or 3-positions or a 5-aminoisoxazole which may be substituted in the 3-position into a Schiff base and subsequent condensation of the Schiff base with thioglycolic acid or a substituted thioglycolic acid. The new compounds are useful antiinflammatories.

    Abstract translation: 可以在1-,3-,5-,7-和/或8-位置被取代的7,8-二氢-4-氧代吡唑并[3,4-d] [1,3]噻吩并与相应的异恶唑并[ 可以在3-,5-,7-和/或8-位置被取代的5,4-d] [1,3]硫杂吗啉是通过将可被取代的5-氨基吡唑转化成1-和/ 或3-位或5-氨基异恶唑,其可以在3-位被取代成席夫碱,随后将席夫碱与巯基乙酸或取代的巯基乙酸缩合。 新化合物是有用的抗炎药。

Patent Agency Ranking